Showing results (21-30 of 995) with videos related to

Sort By:
Pageof 100
Seminars in Oncology|April 1, 2005
Mammalian target of rapamycinFunda Meric-Bernstam, Gordon B Mills
Nature Reviews. Clinical Oncology|August 2, 2012
Overcoming implementation challenges of personalized cancer therapyFunda Meric-Bernstam, Gordon B Mills
Bioinformatics (Oxford, England)|June 10, 2010
Sparse multitask regression for identifying common mechanism of response to therapeutic targetsKai Zhang, Joe W Gray, Bahram Parvin
Drug Metabolism and Pharmacokinetics|January 30, 2016
New era of integrated cancer biomarker discovery using reverse-phase protein arraysSatoshi S Nishizuka, Gordon B Mills
Nature Reviews. Cancer|August 2, 2003
The emerging role of lysophosphatidic acid in cancerGordon B Mills, Wouter H Moolenaar
Cancer Discovery|May 16, 2012
Dissecting "PI3Kness": the complexity of personalized therapy for ovarian cancerRobert C Bast, Gordon B Mills
Pharmacogenomics|January 26, 2016
Targeting therapeutic liabilities engendered by PIK3R1 mutations for cancer treatmentLydia Wt Cheung, Gordon B Mills
Molecular & Cellular Oncology|June 17, 2016
p85α neomorphic mutants: splitting away from the canonical pathLydia Wt Cheung, Gordon B Mills
Nature Medicine|October 27, 2004
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancersKwai Wa Cheng, John P Lahad, Wen-Lin Kuo, et al.
Pageof 100